Katina Dorton - Jun 13, 2023 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role
Director
Signature
/s/ Katina Dorton
Stock symbol
TCRX
Transactions as of
Jun 13, 2023
Transactions value $
$0
Form type
4
Date filed
6/15/2023, 06:17 PM
Previous filing
Jun 29, 2022
Next filing
Jun 29, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRX Stock Option (Right to Buy) Award $0 +35K $0.00 35K Jun 13, 2023 Voting Common Stock 35K $2.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 13, 2024 and (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service at such time.